Receptor for AGE (RAGE) mediates neointimal formation in response to arterial injury

被引:155
作者
Zhou, ZM
Wang, K
Penn, MS
Marso, SP
Lauer, MA
Forudi, F
Zhou, XR
Qu, W
Lu, Y
Stern, DM
Schmidt, AM
Lincoff, AM
Topol, EJ
机构
[1] Cleveland Clin Fdn, Dept Cardiovasc Med, Expt Intervent Lab, Cleveland, OH 44195 USA
[2] St Lukes Hosp, Mid Amer Heart Inst, Kansas City, MO 64111 USA
[3] Borgess Hosp, Res Inst, Kalamazoo, MI USA
[4] Columbia Univ, Coll Phys & Surg, New York, NY USA
关键词
diabetes mellitus; angioplasty; restenosis; receptors;
D O I
10.1161/01.CIR.0000063577.32819.23
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background - Receptor for advanced-glycation end products ( RAGE) and its ligands AGEs and S100/calgranulins have been implicated in a range of disorders. However, the role of RAGE/ligand interaction in neointimal hyperplasia after vascular injury remains unclear. Methods and Results - We examined the expression of RAGE and its ligands after balloon injury of the carotid artery in both Zucker diabetic and nondiabetic rats. Using a soluble portion of the extracellular domain of RAGE, we determined the effects of suppressing RAGE/ligand interaction on vascular smooth muscle cell (VSMC) proliferation and neointimal formation after arterial injury. We demonstrate a significantly increased accumulation of AGE and immunoreactivities of RAGE and S100/calgranulins in response to balloon injury in diabetic compared with nondiabetic rats. Blockade of RAGE/ligand interaction significantly decreased S100-stimulated VSMC proliferation in vitro and bromodeoxyuridine ( BrdU) - labeled proliferating VSMC in vivo, and suppressed neointimal formation and increased luminal area in both Zucker diabetic and nondiabetic rats. Conclusions - These findings indicate that RAGE/ligand interaction plays a key role in neointimal formation after vascular injury irrespective of diabetes status and suggest a novel target to minimize neointimal hyperplasia.
引用
收藏
页码:2238 / 2243
页数:6
相关论文
共 27 条
[1]   Advanced glycation end products activate endothelium through signal-transduction receptor RAGE - A mechanism for amplification of inflammatory responses [J].
Basta, G ;
Lazzerini, G ;
Massaro, M ;
Simoncini, T ;
Tanganelli, P ;
Fu, CF ;
Kislinger, T ;
Stern, DM ;
Schmidt, AM ;
De Caterina, R .
CIRCULATION, 2002, 105 (07) :816-822
[2]  
BRETT J, 1993, AM J PATHOL, V143, P1699
[3]   ADVANCED PROTEIN GLYCOSYLATION IN DIABETES AND AGING [J].
BROWNLEE, M .
ANNUAL REVIEW OF MEDICINE, 1995, 46 :223-234
[4]  
BROWNLEE M, 1988, NEW ENGL J MED, V318, P1315
[5]   Advanced glycation end products, oxidant stress and vascular lesions [J].
Chappey, O ;
Dosquet, C ;
Wautier, MP ;
Wautier, JL .
EUROPEAN JOURNAL OF CLINICAL INVESTIGATION, 1997, 27 (02) :97-108
[6]   Diabetes mellitus and the clinical and angiographic outcome after coronary stent placement [J].
Elezi, S ;
Kastrati, A ;
Pache, J ;
Wehinger, A ;
Hadamitzky, M ;
Dirschinger, J ;
Neumann, FJ ;
Schömig, A .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1998, 32 (07) :1866-1873
[7]   Human vascular smooth muscle cells of diabetic origin exhibit increased proliferation, adhesion, and migration [J].
Faries, PL ;
Rohan, DI ;
Takahara, H ;
Wyers, MC ;
Contreras, MA ;
Quist, WC ;
King, GL ;
LoGerfo, FW .
JOURNAL OF VASCULAR SURGERY, 2001, 33 (03) :601-607
[8]   RESPONSE OF THE AORTA OF THE OBESE ZUCKER RAT TO INJURY [J].
HAUDENSCHILD, CC ;
VANSICKLE, W ;
CHOBANIAN, AV .
ARTERIOSCLEROSIS, 1981, 1 (03) :186-191
[9]   The receptor for advanced glycation end products mediates the chemotaxis of rabbit smooth muscle cells [J].
Higashi, T ;
Sano, H ;
Saishoji, T ;
Ikeda, K ;
Jinnouchi, Y ;
Kanzaki, T ;
Morisaki, N ;
Rauvala, H ;
Shichiri, M ;
Horiuchi, S .
DIABETES, 1997, 46 (03) :463-472
[10]   Transgenic expression of human S100A12 induces structural airway abnormalities and limited lung inflammation in a mouse model of allergic inflammation [J].
Bowman, M. A. Hofmann ;
Heydemann, A. ;
Gawdzik, J. ;
Shilling, R. A. ;
Camoretti-Mercado, B. .
CLINICAL AND EXPERIMENTAL ALLERGY, 2011, 41 (06) :878-889